Global Prophylactic Human Vaccines Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 106

Report ID: 3936

In 2018, the global Prophylactic Human Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Prophylactic Human Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prophylactic Human Vaccines development in United States, Europe and China.

The key players covered in this study
ALK
Altimmune
Bavarian Nordic
BiondVax Pharmaceuticals
Bharat Biotech International
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute of India
Shanghai BravoBio
Seqirus
SK Chemicals
Takeda Pharmaceutical Company
Zydus Cadila

Market segment by Type, the product can be split into
Type I
Type II

Market segment by Application, split into
Pediatric Prophylactic Vaccines
Adult Prophylactic Vaccines

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Prophylactic Human Vaccines status, future forecast, growth opportunity, key market and key players.
To present the Prophylactic Human Vaccines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Prophylactic Human Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prophylactic Human Vaccines Market Size Growth Rate by Type (2014-2025)
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Prophylactic Human Vaccines Market Share by Application (2014-2025)
1.5.2 Pediatric Prophylactic Vaccines
1.5.3 Adult Prophylactic Vaccines
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Prophylactic Human Vaccines Market Size
2.2 Prophylactic Human Vaccines Growth Trends by Regions
2.2.1 Prophylactic Human Vaccines Market Size by Regions (2014-2025)
2.2.2 Prophylactic Human Vaccines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Prophylactic Human Vaccines Market Size by Manufacturers
3.1.1 Global Prophylactic Human Vaccines Revenue by Manufacturers (2014-2019)
3.1.2 Global Prophylactic Human Vaccines Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Prophylactic Human Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Prophylactic Human Vaccines Key Players Head office and Area Served
3.3 Key Players Prophylactic Human Vaccines Product/Solution/Service
3.4 Date of Enter into Prophylactic Human Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Prophylactic Human Vaccines Market Size by Type (2014-2019)
4.2 Global Prophylactic Human Vaccines Market Size by Application (2014-2019)

5 United States
5.1 United States Prophylactic Human Vaccines Market Size (2014-2019)
5.2 Prophylactic Human Vaccines Key Players in United States
5.3 United States Prophylactic Human Vaccines Market Size by Type
5.4 United States Prophylactic Human Vaccines Market Size by Application

6 Europe
6.1 Europe Prophylactic Human Vaccines Market Size (2014-2019)
6.2 Prophylactic Human Vaccines Key Players in Europe
6.3 Europe Prophylactic Human Vaccines Market Size by Type
6.4 Europe Prophylactic Human Vaccines Market Size by Application

7 China
7.1 China Prophylactic Human Vaccines Market Size (2014-2019)
7.2 Prophylactic Human Vaccines Key Players in China
7.3 China Prophylactic Human Vaccines Market Size by Type
7.4 China Prophylactic Human Vaccines Market Size by Application

8 Japan
8.1 Japan Prophylactic Human Vaccines Market Size (2014-2019)
8.2 Prophylactic Human Vaccines Key Players in Japan
8.3 Japan Prophylactic Human Vaccines Market Size by Type
8.4 Japan Prophylactic Human Vaccines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Prophylactic Human Vaccines Market Size (2014-2019)
9.2 Prophylactic Human Vaccines Key Players in Southeast Asia
9.3 Southeast Asia Prophylactic Human Vaccines Market Size by Type
9.4 Southeast Asia Prophylactic Human Vaccines Market Size by Application

10 India
10.1 India Prophylactic Human Vaccines Market Size (2014-2019)
10.2 Prophylactic Human Vaccines Key Players in India
10.3 India Prophylactic Human Vaccines Market Size by Type
10.4 India Prophylactic Human Vaccines Market Size by Application

11 Central & South America
11.1 Central & South America Prophylactic Human Vaccines Market Size (2014-2019)
11.2 Prophylactic Human Vaccines Key Players in Central & South America
11.3 Central & South America Prophylactic Human Vaccines Market Size by Type
11.4 Central & South America Prophylactic Human Vaccines Market Size by Application

12 International Players Profiles
12.1 ALK
12.1.1 ALK Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prophylactic Human Vaccines Introduction
12.1.4 ALK Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.1.5 ALK Recent Development
12.2 Altimmune
12.2.1 Altimmune Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prophylactic Human Vaccines Introduction
12.2.4 Altimmune Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.2.5 Altimmune Recent Development
12.3 Bavarian Nordic
12.3.1 Bavarian Nordic Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prophylactic Human Vaccines Introduction
12.3.4 Bavarian Nordic Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.3.5 Bavarian Nordic Recent Development
12.4 BiondVax Pharmaceuticals
12.4.1 BiondVax Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prophylactic Human Vaccines Introduction
12.4.4 BiondVax Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.4.5 BiondVax Pharmaceuticals Recent Development
12.5 Bharat Biotech International
12.5.1 Bharat Biotech International Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prophylactic Human Vaccines Introduction
12.5.4 Bharat Biotech International Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.5.5 Bharat Biotech International Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prophylactic Human Vaccines Introduction
12.6.4 GlaxoSmithKline Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Hualan Biological Engineering
12.7.1 Hualan Biological Engineering Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prophylactic Human Vaccines Introduction
12.7.4 Hualan Biological Engineering Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.7.5 Hualan Biological Engineering Recent Development
12.8 Janssen Pharmaceuticals
12.8.1 Janssen Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prophylactic Human Vaccines Introduction
12.8.4 Janssen Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.8.5 Janssen Pharmaceuticals Recent Development
12.9 MedImmune
12.9.1 MedImmune Company Details
12.9.2 Company Description and Business Overview
12.9.3 Prophylactic Human Vaccines Introduction
12.9.4 MedImmune Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.9.5 MedImmune Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Prophylactic Human Vaccines Introduction
12.10.4 Merck Revenue in Prophylactic Human Vaccines Business (2014-2019)
12.10.5 Merck Recent Development
12.11 Pfizer
12.12 Sanofi Pasteur
12.13 Serum Institute of India
12.14 Shanghai BravoBio
12.15 Seqirus
12.16 SK Chemicals
12.17 Takeda Pharmaceutical Company
12.18 Zydus Cadila

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details